(Q79366637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Aripiprazole augmentation for treatment of patients with inadequate antidepressants response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Chi-Un Pae

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Ashwin A Patkar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Tae-Youn Jun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Chul Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Prakash S Masand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

In-Ho Paik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

published in

Depression and Anxiety

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

522-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

Aripiprazole augmentation in treatment-resistant depression

22 December 2019

cites work

1 reference

7 January 2021

A rating scale for drug-induced akathisia

1 reference

7 January 2021

Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.

1 reference

7 January 2021

Definition and epidemiology of treatment-resistant depression

1 reference

7 January 2021

Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience

1 reference

7 January 2021

Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders

1 reference

7 January 2021

Aripiprazole as an adjunctive treatment for refractory major depression

1 reference

7 January 2021

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

7 January 2021

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

7 January 2021

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

7 January 2021

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

7 January 2021

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

7 January 2021

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

7 January 2021

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

7 January 2021

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

7 January 2021

Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder

1 reference

7 January 2021

Low-dose risperidone augmentation of antidepressants in nonpsychotic depressive disorders with suicidal ideation

1 reference

7 January 2021

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111388%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference